Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 1000
Summary
- Conditions
- Ovarian Cancer
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Primary Objectives · To provide genomic profiling for BRCA1 and BRCA2 mutational status in patients' with high grade serous ovarian cancer. Secondary Objectives To track the number of women with high grade serous ovarian cancer who are being screened in Princess Margaret Cancer Center for mutations ...
Primary Objectives · To provide genomic profiling for BRCA1 and BRCA2 mutational status in patients' with high grade serous ovarian cancer. Secondary Objectives To track the number of women with high grade serous ovarian cancer who are being screened in Princess Margaret Cancer Center for mutations in BRCA1/2 To track accrual rates and clinical outcomes in patients with high grade serous ovarian cancer who are BRCA1/2-positive To correlate impact of BRCA1/2 mutational status on clinical outcome To track utilization of genetic counseling services at Princess Margaret Cancer Centre
Tracking Information
- NCT #
- NCT02341118
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Amit Oza University Health Network, Toronto
Get Well Soon